ArticleFood chemistry: X2026
Mechanism of blueberry anthocyanins inhibit glycation of bovine serum albumin-fructose/methylglyoxal revealed by LC ETD MS/MS.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In order to investigate the inhibitory mechanism of blueberry anthocyanins (BAs) on glycation, bovine serum albumin-fructose (BSA-Fru) and BSA-methylglyoxal (BSA-MGO) models induced by ultrasound-microwave were implemented. BAs exhibited concentration-dependent inhibition of glycation, reducing advanced glycation end products (AGEs) formation by approximately 60% in the BSA-Fru model and 32.58% in the BSA-MGO model at 1.0 mg/mL. Notably, BAs significantly increased the molecular weight of glycated BSA and maintain BSA secondary structure by mitigating the decrease in α-helix content. LC-ETD-MS/MS analysis revealed that BAs reduced glycation sites from 23 to 18 in BSA-Fru and from 11 to 6 in BSA-MGO, with key sites including K75 and K88 being protected. Additionally, BAs increased the molecular weight of glycated BSA and mitigated the decrease in α-helix content. These findings suggest that BAs is potential effective glycation inhibitors and could be used in food processing to inhibit the formation of AGEs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.